XLV The Health Care Select Sector SPDR® Fund
- 147.740
- +0.870+0.59%
Iterum Therapeutics Notified Pfizer, Electing To Defer Milestone Payment For 2 Years For ORLYNVAH, Or Until Oct 25, 2026
Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
Stocks That Hedge Funds Moved From Long to Short in August - Jefferies
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
Abbott Laboratories Shares Are Trading Higher After the Company Announced It Along With Reckitt Benckiser Won Its First Trial in Premature-infant Formula Litigation and Is Cleared of Allegations of Hiding Bowel Disease Risks.
Price Over Earnings Overview: AbbVie
Myriad Genetics Plummets 20% as UnitedHealth Changes GeneSight Coverage
BMO Capital Maintains Outperform on Merck & Co, Lowers Price Target to $136
Countdown to the USA election, when will the results be announced? Please keep this viewing guide handy!
"The big show" is about to begin, grab your "program."
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
Merck & Co Analyst Ratings
Novo Nordisk Succeeds in Late-stage Trial for Weight Loss Therapy in MASH
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Ahead of Key Jobs Report
Wall Street Suffers October Blues as Benchmark S&P 500 Snaps Five-month Win Streak
Abbott Jumps as Jury Says Company, Reckitt Not Liable in Infant Formula Case
Amgen Analyst Ratings
Barclays Maintains Overweight on Eli Lilly, Lowers Price Target to $975
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Live On CNBC, Stephanie Link Announces Bought More Eli Lilly And Company
Market Analysis: AbbVie And Competitors In Biotechnology Industry